Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Eye Care

Journal Scan / Research · March 10, 2022

Efficacy of 0.1% Nepafenac vs 0.09% Bromfenac Eye Drops for Post LPI Inflammation

Ophthalmology Glaucoma

 

Additional Info

Disclosure statements are available on the authors' profiles:

Ophthalmology Glaucoma
0.1% Nepafenac Vs. 0.09% Bromfenac Eye Drops for Post Laser Peripheral Iridotomy Inflammation - A Randomised Controlled Trial
Ophthalmol Glaucoma 2022 Feb 20;[EPub Ahead of Print], LG Shankar, A Odayappan, AG Shukla, V C R, R Venkatesh, S Kavitha

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading